Pilot study: The influence of commonly used medicines in obstetric care on the fetal ECG Short title: FEMME (Fetal Ecg and Maternal MEdication) - FEMME (Fetal Ecg and Maternal MEdication)

Maxima Medisch Centrum0 个研究点目标入组 750 人开始时间: 待定最近更新: 2024年4月29日

适应症

试验速览

暂无简介。

•Pregnant women, carrying a healthy, singleton fetus with a gestational age between 20 and 42 weeks, receiving one or more of the following medicines; tocolytic drugs, corticosteroids, antihypertensive agents or medication for sedation or pain relief during labour. Patients receiving both tocolytic drugs and corticosteroids at the same time can participate in this study, since this is standard care nowadays. Also patients receiving antihypertensive agents and corticosteroids simultaneously can be included in this study. In this way, we will get information that is applicable in daily clinical practice.

•Women under the age of 18 years old, using other medicines than examined in this study, multiple pregnancies, women carrying a fetus with a known congenital malformation and fetuses with an intra-uterine growth restriction are excluded (defined as a fetal growth lower than p5 as estimated by echography). Fetal congenital malformations discovered after inclusion will be analysed separately.

发起方

Maxima Medisch Centrum